Medications
British drugs firm GSK settles US drug disputes for $3.0 bln
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Nov 3, 2011
0
0
